mifepristone has been researched along with Angiogenesis, Pathologic in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abernethie, AJ; Andrew, R; Gastaldello, A; Hadoke, PW; Livingstone, DE; Maltese, G; McInnes, KJ; Morgan, RA; Small, GR; Walker, BR | 1 |
| Abernethie, A; Andrew, R; Hadoke, P; Halligan, D; Keen, J; Livingstone, D; Maltese, G; Morgan, R; O'Callaghan, A; Walker, B | 1 |
| Huang, L; Qian, Z; Zhou, F | 1 |
| Choi, MR; Christov, K; Ivancic, D; Khan, SA; Lee, O | 1 |
| Cong, MH; Sun, JZ; Tian, XS; Wu, GJ; Zhou, WH | 1 |
| Jin, ZJ; Li, YL; Li, YR; Wang, L; Zhang, HY | 1 |
| Ali, S; Hadoke, PW; Heck, MM; Logie, JJ; Marshall, KM; Walker, BR | 1 |
| Benakanakere, I; Besch-Williford, C; Brandt, S; Ellersieck, MR; Hyder, SM; Molinolo, A; Schnell, J | 1 |
| Besch-Williford, C; Brekken, RA; Hyder, SM; Liang, Y | 1 |
| Nishizawa, Y; Petrow, V; Terada, N; Yamamoto, T | 1 |
| Hyder, SM; Murthy, L; Stancel, GM | 1 |
| King, I; Sartorelli, AC; Violette, SM | 1 |
12 other study(ies) available for mifepristone and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Comparison of mechanisms of angiostasis caused by the anti-inflammatory steroid 5α-tetrahydrocorticosterone versus conventional glucocorticoids.
Topics: Animals; Anti-Inflammatory Agents; Corticosterone; Dexamethasone; Glucocorticoids; Hydrocortisone; Male; Mice; Mice, Inbred C57BL; Mifepristone; Neovascularization, Pathologic; Receptors, Glucocorticoid | 2022 |
Species-specific regulation of angiogenesis by glucocorticoids reveals contrasting effects on inflammatory and angiogenic pathways.
Topics: Angiogenesis Inhibitors; Animals; Blood Vessels; Female; Gene Expression Profiling; High-Throughput Nucleotide Sequencing; Horse Diseases; Horses; Hydrocortisone; Inflammation; Male; Metabolic Networks and Pathways; Mice; Mifepristone; Neovascularization, Pathologic; Real-Time Polymerase Chain Reaction; Species Specificity; Transcriptome | 2018 |
Low-dose mifepristone increased angiogenesis in a manner involving AQP1.
Topics: Animals; Aquaporin 1; Contraceptives, Oral, Synthetic; Embryo Implantation; Female; Humans; Mice; Mifepristone; Neovascularization, Pathologic | 2019 |
Progesterone receptor antagonism inhibits progestogen-related carcinogenesis and suppresses tumor cell proliferation.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiogenesis Inhibitors; Animals; Antigens, CD34; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Female; Hormone Antagonists; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Methylnitrosourea; Mice; Mifepristone; Neovascularization, Pathologic; Norpregnadienes; Progesterone; Progestins; Rats; Receptors, Estrogen; Receptors, Progesterone; Time Factors | 2016 |
[Inhibitive effects of mifepristone on growth of breast cancer: experiment with animal model].
Topics: Animals; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Female; Hormone Antagonists; Humans; Immunohistochemistry; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Mifepristone; Neovascularization, Pathologic; Random Allocation; Receptors, Estrogen; Receptors, Progesterone; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2008 |
[Gene therapy based on inducible IL-12 gene in a mouse model of orthotopically transplanted H22 hepatoma].
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Female; Genetic Therapy; Humans; Interferon-gamma; Interleukin-12; Lac Operon; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mifepristone; Neoplasm Transplantation; Neovascularization, Pathologic; Nitric Oxide; Plasmids; Proliferating Cell Nuclear Antigen; Random Allocation | 2010 |
Glucocorticoid-mediated inhibition of angiogenic changes in human endothelial cells is not caused by reductions in cell proliferation or migration.
Topics: Aorta; Bromodeoxyuridine; Cell Movement; Cell Proliferation; Cell Survival; Collagen; Drug Combinations; Endothelial Cells; Glucocorticoids; Humans; Hydrocortisone; Laminin; Mifepristone; Neovascularization, Pathologic; Proteoglycans; Reverse Transcriptase Polymerase Chain Reaction; Thrombospondin 1; Umbilical Veins | 2010 |
Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Implants; Immunohistochemistry; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mifepristone; Neovascularization, Pathologic; Progesterone; Rats; Rats, Sprague-Dawley; Receptors, Progesterone; Time Factors; Vascular Endothelial Growth Factors | 2006 |
Progestin-dependent progression of human breast tumor xenografts: a novel model for evaluating antitumor therapeutics.
Topics: Angiogenesis Inhibitors; Animals; Aza Compounds; Breast Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cell Growth Processes; Disease Progression; Female; Humans; Medroxyprogesterone Acetate; Mice; Mifepristone; Neoplasms, Hormone-Dependent; Neovascularization, Pathologic; Progesterone; Progesterone Congeners; Progestins; Receptors, Estrogen; Receptors, Progesterone; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2007 |
Angiostatic activities of medroxyprogesterone acetate and its analogues.
Topics: Animals; Cattle; Cell Division; Cells, Cultured; Cornea; Dexamethasone; Endothelium, Vascular; Estradiol; Female; Fibroblast Growth Factor 2; Medroxyprogesterone Acetate; Mifepristone; Neovascularization, Pathologic; Progesterone; Pulmonary Artery; Rabbits; Retinal Vessels; Structure-Activity Relationship | 1994 |
Progestin regulation of vascular endothelial growth factor in human breast cancer cells.
Topics: Breast Neoplasms; Endometrial Neoplasms; Endothelial Growth Factors; Female; Gene Expression Regulation, Neoplastic; Humans; Lymphokines; Medroxyprogesterone Acetate; Megestrol Acetate; Mifepristone; Neoplasm Proteins; Neovascularization, Pathologic; Norethindrone; Norethynodrel; Norgestrel; Progesterone; Progestins; Receptors, Progesterone; Stimulation, Chemical; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1998 |
Induction of the terminal differentiation of a human squamous cell carcinoma by steroids with glucocorticoid activity.
Topics: 17-alpha-Hydroxyprogesterone; Androstanols; Carcinoma, Squamous Cell; Cell Differentiation; Desoxycorticosterone; Dose-Response Relationship, Drug; Glucocorticoids; Humans; Hydrocortisone; Hydroxyprogesterones; In Vitro Techniques; Mifepristone; Mineralocorticoids; Neovascularization, Pathologic; Progesterone; Tretinoin; Tumor Cells, Cultured | 1989 |